Former Director Of FDA's 510(k) Staff To Join Trade Group MDMA
This article was originally published in The Gray Sheet
Executive Summary
Heather Rosecrans, erstwhile director of FDA's 510(k) pre-market program staff, is joining the Medical Device Manufacturers Association to work on regulatory policy for the industry lobbying group
You may also be interested in...
Regulatory News In Brief
J&J's Sedasys appeal docket
Regulatory News In Brief
J&J's Sedasys appeal docket
Former 510(k) Staff Director Takes Critical Look At FDA's Reform Plan
As FDA rolls out changes to its 510(k) review process, Heather Rosecrans, former director of the 510(k) program staff, and now on the industry side of the debate, is watching with keen interest and some trepidation.